Press Releases

Cytel ushers in new era of optimized clinical trial design with launch of Solara™

Cytel is set to revolutionize clinical trial design planning with the launch of SolaraTM, a collaborative decision-support platform for greater development productivity and better business results. Overcoming a critical bottleneck in pharma & biotech The platform will fundamentally reimagine clinical trial design – a process renowned for its tight design timelines and the convoluted process of reaching stakeholder consensus on the most suitable trial design. The only platform of its kind The platform applies massive cloud computing power to rapidly explore an exponentially larger design space than is possible using traditional design methods. It is the only platform to integrate statistical and business considerations into the trial design process and includes intuitive visualization tools to optimize decision-making.

BioIVT Launches HEPATOMUNE Kit to Facilitate Liver Toxicity and Inflammation Studies for Drug Discovery and Disease Research

Applications for this model include assessing drug candidates’ hepatotoxicity, and studying inflammation-related diseases 

ATMPS advanced therapy blockchain platform has successful testing with NHS partners

New ‘blockchain ecosystem’ has potential to track, from vein-to-vein, advanced therapies

Alfa Chemistry Testing Lab Builds an Exclusive Regulatory Resource Section on Its Website

SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology

SB3000 partners with Evaxion biotech to provide rapid scale up for commercial production of corona virus vaccines with its continuous manufacturing technology.

Sakura Finetek Europe launches Tissue-Tek SmartConnect®, a new chapter in automation and the next step for laboratories in achieving future-proof pathology.

https://news.lifesciencenewswire.com/newsroom/sakura-finetek-europe-launches-tissue-tek-smartconnect

Ben-Gurion University Researcher Develops and Licenses New Clinical Trials Platform Based on Machine Learning

The new platform leverages machine learning to optimize a clinical trial’s chances of success, by analyzing patient population recruitment and dropout rate, as well as identifying and prioritizing monitored markers. It provides efficient pre-trial recommendations, in-trial interim analysis, and post-trial insights for next trial preparation, as well as potential salvage options in case of failure.

Aurinia Pharmaceuticals selects MyMeds&Me’s Reportum QuickStart platform to streamline drug safety reporting

MyMeds&Me, a leading provider of drug safety software to transform the end-to-end pharmacovigilance process, have today announced that Aurinia Pharmaceuticals Inc. has selected the Reportum QuickStart platform to streamline the capture, processing and management of safety data for the investigational drug voclosporin, following recent positive Phase 3 results.

Atik Cameras Develops New Products for Use with qPCR Instruments for Accurate, Reliable COVID-19 Testing

Atik Cameras today announced the launch of the VS255 and VS825 cameras for use specifically with quantitative Polymerase Chain Reaction (qPCR) instruments for accurate, reliable COVID-19 Testing – which I thought would be of interest to you and your readers. The qPCR test is vital in pinpointing COVID-19 positive cases and the timeframes in which these cases pose the greatest risk of spreading the SARS-CoV-2 virus to the wider population. With the paramount importance of the COVID-19 challenge, it was vital that Atik Cameras provided products that were well suited to the task. The commercially-competitive, custom VS255 and VS825 cameras offer superior sensitivity and image quality enabling Original Equipment Manufacturers (OEMs) and clinical diagnostic laboratories to achieve accurate diagnosis of active COVID-19 infections.

Dublin-based start-up launch Wirano – a global digital platform for organizing clinical trials

A Dublin-based tech start-up today announced the launch of Wirano – a digital platform for the rapid and effective organization of clinical trials – which I thought would be of interest to you and your readers. The success rate of clinical trials is just 14%, with patient recruitment being a key hurdle. Wirano aims to improve this rate by optimizing the patient recruitment process, improving site and investigator selection procedures, and creating reliable channels for effective communication between all participants.

BOC Sciences Lanuched A New Biotinylation Platform

Global Genes and Rady Children’s Institute for Genomic Medicine Partner to Develop Next-Generation Support Network for Families with Diagnosed Gene-Based Rare Diseases

Global Genes, a leading rare disease patient advocacy organization, is pleased to announce a new partnership with Rady Children’s Institute for Genomic Medicine (RCIGM) to develop a next-generation support network for families with gene-based diagnosed rare diseases.

Notable Labs Announces Addition of Thomas Bock to Board of Directors

Notable, which is redefining cancer treatment by taking a functional approach to precision oncology in hematological cancers, today announced the addition of Dr. Thomas A. Bock to its board of directors.

Knowledge to Practice (K2P) Appoints David B. Nash, MD, MBA, as Chairman of Advisory Board

Knowledge to Practice (K2P), a leading provider of personalized, competency-based lifelong learning for practicing physicians, hospitals and healthcare systems, today announced it has named David B. Nash, MD, MBA, as Chairman of its Advisory Board. A board-certified internist and the Founding Dean Emeritus at Jefferson College of Population Health, Dr. Nash advised on the development of the recently launched CurrentMD COVID curriculum and is helping to conceptualize K2P’s new Complex Diseases curriculum, set to launch in 2021.

WCG Leads the Way and Sets a New Standard - Announcing the Formation of WCG IRB and the Launch of New WCG IRB Connexus™

WCG has unified its five IRBs – Western IRB (WIRB), Copernicus Group IRB, Midlands IRB, New England IRB, and Aspire IRB – in a single brand, WCG IRB. It has also launched a new technology – WCG IRB Connexus – to support clients’ ethical review submissions and management. Further information is available on it new website at www.wcgirb.com.

CATO SMS Unveils New Brand

CATO SMS unveiled its new brand today, revealing an updated look and logo capturing the company’s powerful offering following the merger of CATO Research, LLC and Specialized Medical Services-oncology BV (SMS-oncology).

Biofourmis Closes $100 Million Series C Funding Round Led by SoftBank Vision Fund 2 to Accelerate U.S. and Global Expansion

Digital therapeutics leader Biofourmis closes $100 million Series C led by SoftBank. Funds will help accelerate virtual clinical trials business, among other initiatives.

Patient Groups Issue Guidelines for Ensuring Access to Care and Treatment for Rare Disease Patients, Citing Critical Needs and Gaps Further Exposed and Stretched During COVID-19

Global Genes and the Child Neurology Foundation, as part of the Rare Access to Critical Therapies (ACT) collaboration, announced today the joint release of a report highlighting and supporting guiding principles of rare disease care and access — which the groups assert are universally relevant to all patients with rare diseases.

Litmus Health Achieves HIPAA Compliance and NIST Cybersecurity Framework Adherence for Real World Data Infrastructure

Litmus Health, the research-ready infrastructure platform for real world data, that you might find interesting. As a bit of background, Litmus collects real world data from wearables and sensors, and analyzes these data for inclusion in clinical trials for their customers in pharma. This morning, the company announced that after a thorough third party security assessment, its infrastructure was determined to be secure and compliant when measured against federal security regulations.

APIS Assay Technologies Ltd expands bioinformatics expertise with acquisition of Beogenomics

Please see below for the latest news from APIS Assay Technologies Ltd announcing the acquisition of Beogenomics, a specialised software developer with major expertise in Bioinformatics and Artificial Intelligence (BIOX). Beogenomics develops both on-prem and secure cloud-based data analysis solutions — helping customers design, build and run custom tailored genomics & proteomics pipelines. The integration into Manchester-based APIS will support the launch of a new BIOX Service Line as part of the company’s ongoing Biomarker Research and Development activities.